Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
AJR. American Journal of Roentgenology
|
October 1, 1987
A digital radiology imaging system: description and clinical evaluation
A W Templeton, S J Dwyer, G G Cox, et al.
Radiology
|
August 1, 1984
An on-line digital image management system
A W Templeton, S J Dwyer, J A Johnson, et al.
Chest
|
April 20, 1999
Efficacy of salmeterol xinafoate in the treatment of COPD
D A Mahler, J F Donohue, R A Barbee, et al.
Radiology
|
July 1, 1982
The cost of managing digital diagnostic images
S J Dwyer, A W Templeton, N L Martin, et al.
Genes and Immunity
|
October 26, 2007
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations
G Zhu, K Carlsen, K-H Carlsen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2014
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine
J M Witkin, C Overshiner, X Li, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 8, 2008
Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes
S G Pillai, Y Tang, E van den Oord, et al.
Human Genetics
|
December 28, 2011
Genetic association between human chitinases and lung function in COPD
F Aminuddin, L Akhabir, D Stefanowicz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2017
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive <i>N</i>-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression
J M Witkin, S N Mitchell, K A Wafford, et al.
Pharmacology, Biochemistry, and Behavior
|
March 3, 2019
The α2,3-selective potentiator of GABA<sub>A</sub> receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats
J M Witkin, R Cerne, P G Davis, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
AJR. American Journal of Roentgenology
|
October 1, 1987
A digital radiology imaging system: description and clinical evaluation
A W Templeton, S J Dwyer, G G Cox, et al.
Radiology
|
August 1, 1984
An on-line digital image management system
A W Templeton, S J Dwyer, J A Johnson, et al.
Chest
|
April 20, 1999
Efficacy of salmeterol xinafoate in the treatment of COPD
D A Mahler, J F Donohue, R A Barbee, et al.
Radiology
|
July 1, 1982
The cost of managing digital diagnostic images
S J Dwyer, A W Templeton, N L Martin, et al.
Genes and Immunity
|
October 26, 2007
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations
G Zhu, K Carlsen, K-H Carlsen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2014
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine
J M Witkin, C Overshiner, X Li, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 8, 2008
Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes
S G Pillai, Y Tang, E van den Oord, et al.
Human Genetics
|
December 28, 2011
Genetic association between human chitinases and lung function in COPD
F Aminuddin, L Akhabir, D Stefanowicz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2017
Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive <i>N</i>-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression
J M Witkin, S N Mitchell, K A Wafford, et al.
Pharmacology, Biochemistry, and Behavior
|
March 3, 2019
The α2,3-selective potentiator of GABA<sub>A</sub> receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats
J M Witkin, R Cerne, P G Davis, et al.
Page
of 9